Study: Cholesterol was lowered with an oral PCSK9 inhibitor.

Published Date: 08 Mar 2023

A new study conducted by Baylor College of Medicine and presented at the American College of Cardiology Annual Scientific Session as well as the World Congress of Cardiology shows that an oral PCSK9 inhibitor called MK-0616...

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The clinical trial of ENZAMET shows promise as a treatment for prostate cancer.

2.

Asymptomatic Brain Metastases in EGFR-Mutant NSCLC

3.

BlurryScope: A compact, AI-powered microscope for rapid, cost-effective cancer scoring

4.

New study highlights success of financial toxicity tumor board in reducing cancer treatment costs

5.

Older Men Increasingly Overtreated for Prostate Cancer, Study Suggests


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot